A detailed history of Comerica Bank transactions in Guardant Health, Inc. stock. As of the latest transaction made, Comerica Bank holds 67,836 shares of GH stock, worth $2.21 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
67,836
Previous 68,128 0.43%
Holding current value
$2.21 Million
Previous $1.97 Million 20.95%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$22.3 - $36.29 $6,511 - $10,596
-292 Reduced 0.43%
67,836 $1.56 Million
Q2 2024

Aug 15, 2024

BUY
$16.07 - $31.84 $1.07 Million - $2.12 Million
66,527 Added 4155.34%
68,128 $1.97 Million
Q1 2024

May 15, 2024

SELL
$17.13 - $26.91 $138,907 - $218,213
-8,109 Reduced 83.51%
1,601 $33,000
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $75,357 - $103,014
-3,492 Reduced 26.45%
9,710 $262,000
Q3 2023

Nov 21, 2023

SELL
$25.8 - $39.97 $8,514 - $13,190
-330 Reduced 2.44%
13,202 $391,000
Q2 2023

Aug 22, 2023

BUY
$20.94 - $38.01 $283,360 - $514,351
13,532 New
13,532 $64,000
Q3 2022

Oct 28, 2022

BUY
$43.66 - $61.0 $152,242 - $212,707
3,487 Added 4.09%
88,717 $3.79 Million
Q2 2022

Aug 02, 2022

BUY
$28.82 - $77.35 $2.2 Million - $5.92 Million
76,488 Added 874.95%
85,230 $3.96 Million
Q1 2022

Apr 27, 2022

BUY
$48.25 - $100.49 $421,801 - $878,483
8,742 New
8,742 $579,000
Q3 2021

Nov 22, 2021

SELL
$98.77 - $132.17 $1.06 Million - $1.42 Million
-10,778 Closed
0 $0
Q2 2021

Aug 26, 2021

SELL
$109.77 - $165.68 $42,700 - $64,449
-389 Reduced 3.48%
10,778 $1.34 Million
Q1 2021

Apr 28, 2021

SELL
$127.04 - $179.1 $11,814 - $16,656
-93 Reduced 0.83%
11,167 $1.7 Million
Q4 2020

Jan 28, 2021

SELL
$99.96 - $135.93 $40,383 - $54,915
-404 Reduced 3.46%
11,260 $1.45 Million
Q3 2020

Oct 30, 2020

SELL
$80.32 - $111.8 $5,863 - $8,161
-73 Reduced 0.62%
11,664 $1.3 Million
Q2 2020

Jul 31, 2020

BUY
$60.49 - $97.5 $42,101 - $67,860
696 Added 6.3%
11,737 $952,000
Q1 2020

May 01, 2020

SELL
$59.04 - $88.81 $19,601 - $29,484
-332 Reduced 2.92%
11,041 $768,000
Q4 2019

Feb 07, 2020

SELL
$59.49 - $82.78 $65,914 - $91,720
-1,108 Reduced 8.88%
11,373 $888,000
Q3 2019

Oct 31, 2019

BUY
$62.59 - $110.3 $95,887 - $168,979
1,532 Added 13.99%
12,481 $796,000
Q2 2019

Aug 02, 2019

BUY
$63.94 - $91.11 $700,079 - $997,563
10,949 New
10,949 $0

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.